Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sridhar Nimmagadda

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Frontiers in Oncology|June 5, 2012
Differential Expression of Chemokine Receptors and their Roles in Cancer ImagingSridhar Nimmagadda
Cancers|November 3, 2020
Quantifying PD-L1 Expression to Monitor Immune Checkpoint Therapy: Opportunities and ChallengesSridhar Nimmagadda
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2021
Imaging PD-L1 Expression in Melanoma Brain MetastasesSridhar Nimmagadda
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2025
SIRPα Immuno-PET Provides a Pan-Myeloid View of Immune Activity During COVID-19Sridhar Nimmagadda
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2011
CXCR4-based imaging agentsLauren E Woodard, Sridhar Nimmagadda
Frontiers in Oncology|February 11, 2020
Ovarian Cancer Targeted TheranosticsSridhar Nimmagadda, Marie-France Penet
Cancer Metastasis Reviews|May 31, 2008
The role of DNA synthesis imaging in cancer in the era of targeted therapeuticsSridhar Nimmagadda, Anthony F Shields
Molecular Imaging|July 15, 2017
Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding ImmunotherapySamit Chatterjee, Wojciech G Lesniak, Sridhar Nimmagadda
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2009
Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CTSridhar Nimmagadda, Mrudula Pullambhatla, Martin G Pomper
Advances in Cancer Research|October 8, 2014
The intricate role of CXCR4 in cancerSamit Chatterjee, Babak Behnam Azad, Sridhar Nimmagadda
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Frontiers in Oncology|June 5, 2012
Differential Expression of Chemokine Receptors and their Roles in Cancer ImagingSridhar Nimmagadda
Cancers|November 3, 2020
Quantifying PD-L1 Expression to Monitor Immune Checkpoint Therapy: Opportunities and ChallengesSridhar Nimmagadda
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2021
Imaging PD-L1 Expression in Melanoma Brain MetastasesSridhar Nimmagadda
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2025
SIRPα Immuno-PET Provides a Pan-Myeloid View of Immune Activity During COVID-19Sridhar Nimmagadda
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2011
CXCR4-based imaging agentsLauren E Woodard, Sridhar Nimmagadda
Frontiers in Oncology|February 11, 2020
Ovarian Cancer Targeted TheranosticsSridhar Nimmagadda, Marie-France Penet
Cancer Metastasis Reviews|May 31, 2008
The role of DNA synthesis imaging in cancer in the era of targeted therapeuticsSridhar Nimmagadda, Anthony F Shields
Molecular Imaging|July 15, 2017
Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding ImmunotherapySamit Chatterjee, Wojciech G Lesniak, Sridhar Nimmagadda
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2009
Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CTSridhar Nimmagadda, Mrudula Pullambhatla, Martin G Pomper
Advances in Cancer Research|October 8, 2014
The intricate role of CXCR4 in cancerSamit Chatterjee, Babak Behnam Azad, Sridhar Nimmagadda
Pageof 10